ArticleDiabetes, obesity & metabolism2026
Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function.
Hiroki Nobayashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.